{"article": [{"url": "https://www.marketwatch.com/story/moderna-inc-stock-rises-friday-still-underperforms-market-01602275152", "published": 1602261200.0, "headline": "Moderna Inc. stock rises Friday, still underperforms market", "body": "Shares of Moderna Inc. MRNA, +0.09% inched 0.10% higher to $73.00 Friday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index COMP, +1.39% rising 1.39% to 11,579.94 and the Dow Jones Industrial Average DJIA, +0.56% rising 0.57% to 28,586.90. This was the stock's third consecutive day of gains. Moderna Inc. closed $22.21 short of its 52-week high ($95.21), which the company achieved on July 17th. The stock demonstrated a mixed performance when compared to some of its competitors Friday, as AbbVie Inc. ABBV, +0.41% rose 0.41% to $87.70 and Amgen Inc. AMGN, -1.41% fell 1.41% to $236.70. Trading volume (4.8 M) remained 6.2 million below its 50-day average volume of 11.0 M. Editor's Note: This story was auto-generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use."}]}